Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 104

Sort by

Sort Order Select

Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Blood (2024) 144 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2024-206919

Published: 2024

Journal Articles

Comparison of the Efficacy and Adverse Effects of Recipient-Derived Versus Donor-Derived CAR-T Cell Therapy for Post-Transplant Relapse in B-ALL

Lichao Liu, Ruihao Huang, Yongxian Hu, Sanfang Tu, Na Wang, Hai Yi, Qiuying Gao, Jian Zhou, Xiaoqi Wang, Cheng Zhang, Xi Zhang

Blood (2024) 144 (Supplement 1): 3469.

https://doi.org/10.1182/blood-2024-207676

Published: 2024

Journal Articles

Combination of Olverembatinib and VP Regimen for Newly Diagnosed Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Xu Tan, Guo Chen, Yingying Ma, Maihong Wang, Qin Wen, Hong Liu, Xi Zhang, Cheng Zhang

Blood (2024) 144 (Supplement 1): 1449.

https://doi.org/10.1182/blood-2024-206572

Published: 2024

Journal Articles

A Multi-Center Clinical Trial of Allogeneic Hematopoietic Stem Cell Transplants in Transfusion Dependent Thalassemia

Blood (2024) 144 (Supplement 1): 378.

https://doi.org/10.1182/blood-2024-204984

Published: 2024

Journal Articles

Sirolimus Combined Dexamethasone As the First-Line Therapy for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Open-Label, Prospective, Randomized Controlled Clinical Trial

Yimei Feng, Hanqing Zeng, Yi Liao, Yi Yang, Wenzheng Yu, Changyong Yuan, Guojun Li, Zhanshu Liu, Huae Shu, Guoxiang Zhang, Yaqing Feng, Chunfang Peng, Xiaoli Chen, Jia Liu, Han Yao, Ming Hou, Xi Zhang

Blood (2024) 144 (Supplement 1): 1187.

https://doi.org/10.1182/blood-2024-207041

Published: 2024

Journal Articles

Engineering a Controllable and Reversible Switch for CAR-T Cell Immunotherapy Via a Genetic Code Expansion System

Yue Liu, Lingna An, Xi Zhang

Blood (2024) 144 (Supplement 1): 3433.

https://doi.org/10.1182/blood-2024-202230

Published: 2024

Journal Articles

Venetoclax, Azacitidine, Combined with Low-Dose Cytarabine in Older Newly Diagnosed Acute Myeloid Leukemia：the Result of a Prospective, Multicenter, Open, Randomized Controlled Trials

Blood (2024) 144 (Supplement 1): 2902.

https://doi.org/10.1182/blood-2024-206513

Published: 2024

Journal Articles

Tissue-Resident Double Negative T Cells Mediate Salivary Gland Damage in Chronic Oral Graft-Versus-Host Disease

Ziyi Hu, Yuxi Xu, Yuxuan He, Qing Xu, Ya Zhou, Qi Wang, Xiaodong Xie, Rui Wang, Xiaoqi Wang, Shijie Yang, Qingxiao Song, Xi Zhang

Blood (2024) 144 (Supplement 1): 3391.

https://doi.org/10.1182/blood-2024-199910

Published: 2024

Journal Articles

Preliminary Efficacy of Orelabrutinib Targeted Therapy in Induction Therapy of Primary Central Nervous System Diffuse B-Cell Lymphoma

Sha Zhou, Jun Rao, Xixi Xiang, Yunjing Zeng, Jiali Li, Hanshan Yang, Bo Liu, Xi Zhang, Li Gao

Blood (2024) 144 (Supplement 1): 4496.

https://doi.org/10.1182/blood-2024-207000

Published: 2024

Journal Articles

Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma: Insights from the Phase 2 Fumanba-1 Study

Chunrui Li, Dehui Zou, Di Wang, Baijun Fang, He Huang, Jianyong Li, Bing Chen, Jing Liu, Xi Zhang, Yujun Dong, Kai Hu, Peng Liu, Jianqing Mi, Kaiyang Ding, Zhenyu Li, Qie Dong, Fuyuan Zhang, Guang Hu, Lu-Gui Qiu

Blood (2024) 144 (Supplement 1): 4761.

https://doi.org/10.1182/blood-2024-204355

Published: 2024

Journal Articles

EZH2 Inhibition Alleviates Chronic Graft-Versus-Host Disease By Modulating Lipid Metabolic Reprogramming and Senescence of Neutrophils

Qing Xu, Ya Zhou, Yuxi Xu, Rui Wang, Xiaoqi Wang, Shijie Yang, Qingxiao Song, Xi Zhang

Blood (2024) 144 (Supplement 1): 4777.

https://doi.org/10.1182/blood-2024-206709

Published: 2024

Journal Articles

Weekly Selinexor, Bortizomib and Dexamethasone (SVd) Versus Twice Weekly Bortizomib and Dexamethasone (Vd) in Chinese Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Primary Analysis of Phase 3 Bench Study

Blood (2024) 144 (Supplement 1): 4748.

https://doi.org/10.1182/blood-2024-202893

Published: 2024

Journal Articles

Survival and Risk Prediction Model for Acute Leukemia Patientsundergoing Hematopoietic Stem Cell Transplantation

Xiaoli Chen, Yimei Feng, Jie Tang, Lin Xia, Shanshan Du, Feng Ran, Liquan Jiang, Lei Gao, Xi Zhang

Blood (2024) 144 (Supplement 1): 7450.

https://doi.org/10.1182/blood-2024-207410

Published: 2024

Journal Articles

Safety and Efficacy of Pomalidomide and Azacitidine Combination in MRD-Guided Preemptive Treatment of Acute Leukemia after Allogeneic Stem Cell Transplantation

Lu Wang, Jia Liu, Lidan Zhu, Huanfeng Liu, Shichun Gao, Peiyan Kong, Xi Zhang, Lei Gao

Blood (2024) 144 (Supplement 1): 6176.

https://doi.org/10.1182/blood-2024-205435

Published: 2024

Journal Articles

Exploring Treatment-Driven Subclonal Evolution of Prognostic and Predictive Triple Biomarkers: Dual Gene Fusions and Chimeric RNA Variants in Subtypes of Acute Myeloid Leukemia Patients with KMT2A Rearrangement

Blood (2024) 144 (Supplement 1): 6099.

https://doi.org/10.1182/blood-2024-204217

Published: 2024

Journal Articles

Targeting the Hypoxic Microenvironment in Cutaneous Chronic Graft-Versus-Host Disease through PI3Kδ Inhibition

Yuxi Xu, Ziyi Hu, Guancui Yang, Yuxuan He, Qing Xu, Ya Zhou, Qi Wang, Xiaodong Xie, Rui Wang, Shijie Yang, Xiaoqi Wang, Qingxiao Song, Xi Zhang

Blood (2024) 144 (Supplement 1): 263.

https://doi.org/10.1182/blood-2024-199521

Published: 2024

Journal Articles

Copy Number Variants Identified By Shallow Whole-Genome Sequencing in Multiple Myeloma

Jiali Li, Xixi Xiang, Jun Rao, Sha Zhou, Yunjing Zeng, Xi Zhang, Li Gao

Blood (2024) 144 (Supplement 1): 6931.

https://doi.org/10.1182/blood-2024-206990

Published: 2024

Journal Articles

A Novel Anti-CD20 Monoclonal Antibody for Treating Relapsed Immune Thrombocytopenia

Jia Liu, Han Yao, Jia Liu, Jun Tao, Yimei Feng, Xi Zhang

Blood (2024) 144 (Supplement 1): 5431.

https://doi.org/10.1182/blood-2024-206557

Published: 2024

Journal Articles

Preliminary Results of a Retrospective Study on a Regimen Based on Orelabrutinib Combined with Anti-CD20 Monoclonal Antibody in Patients with Marginal Zone Lymphoma

Hongling Peng, Xixi Xiang, Jun Rao, Wenzhe Yan, Yajuan Cui, Ji Li, Yafeng Jiang, Xi Zhang

Blood (2024) 144 (Supplement 1): 6293.

https://doi.org/10.1182/blood-2024-203787

Published: 2024

Journal Articles

Hematopoietic Stem Cell Transplant with Thiotepa-Based Conditioning for Adult T-ALL

Lu Zhao, Yuqing Liu, Ting Chen, Yimei Feng, Han Yao, Lidan Zhu, Jia Liu, Huanfeng Liu, Shichun Gao, Lu Wang, Shuhan Tang, Lei Gao, Peiyan Kong, Xi Zhang

Blood (2024) 144 (Supplement 1): 7192.

https://doi.org/10.1182/blood-2024-205161

Published: 2024

NARROW

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Comparison of the Efficacy and Adverse Effects of Recipient-Derived Versus Donor-Derived CAR-T Cell Therapy for Post-Transplant Relapse in B-ALL

Combination of Olverembatinib and VP Regimen for Newly Diagnosed Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

A Multi-Center Clinical Trial of Allogeneic Hematopoietic Stem Cell Transplants in Transfusion Dependent Thalassemia

Sirolimus Combined Dexamethasone As the First-Line Therapy for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Open-Label, Prospective, Randomized Controlled Clinical Trial

Engineering a Controllable and Reversible Switch for CAR-T Cell Immunotherapy Via a Genetic Code Expansion System

Venetoclax, Azacitidine, Combined with Low-Dose Cytarabine in Older Newly Diagnosed Acute Myeloid Leukemia：the Result of a Prospective, Multicenter, Open, Randomized Controlled Trials

Tissue-Resident Double Negative T Cells Mediate Salivary Gland Damage in Chronic Oral Graft-Versus-Host Disease

Preliminary Efficacy of Orelabrutinib Targeted Therapy in Induction Therapy of Primary Central Nervous System Diffuse B-Cell Lymphoma

Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma: Insights from the Phase 2 Fumanba-1 Study

EZH2 Inhibition Alleviates Chronic Graft-Versus-Host Disease By Modulating Lipid Metabolic Reprogramming and Senescence of Neutrophils

Weekly Selinexor, Bortizomib and Dexamethasone (SVd) Versus Twice Weekly Bortizomib and Dexamethasone (Vd) in Chinese Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Primary Analysis of Phase 3 Bench Study

Survival and Risk Prediction Model for Acute Leukemia Patientsundergoing Hematopoietic Stem Cell Transplantation

Safety and Efficacy of Pomalidomide and Azacitidine Combination in MRD-Guided Preemptive Treatment of Acute Leukemia after Allogeneic Stem Cell Transplantation

Exploring Treatment-Driven Subclonal Evolution of Prognostic and Predictive Triple Biomarkers: Dual Gene Fusions and Chimeric RNA Variants in Subtypes of Acute Myeloid Leukemia Patients with KMT2A Rearrangement

Targeting the Hypoxic Microenvironment in Cutaneous Chronic Graft-Versus-Host Disease through PI3Kδ Inhibition

Copy Number Variants Identified By Shallow Whole-Genome Sequencing in Multiple Myeloma

A Novel Anti-CD20 Monoclonal Antibody for Treating Relapsed Immune Thrombocytopenia

Preliminary Results of a Retrospective Study on a Regimen Based on Orelabrutinib Combined with Anti-CD20 Monoclonal Antibody in Patients with Marginal Zone Lymphoma

Hematopoietic Stem Cell Transplant with Thiotepa-Based Conditioning for Adult T-ALL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only